Skip to main content

and
  1. No Access

    Article

    Safety and efficacy of Thymosin α1 in the treatment of hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial

    Mortality from hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF) is high. Severe infection is the most important complication that affects the outcomes of ACLF patients. Thymosin α1 (Tα1) c...

    Jun-feng Chen, Shu-ru Chen, Zi-ying Lei, Hui-juan Cao in Hepatology International (2022)

  2. No Access

    Article

    A Novel prognostic scoring system to predict 3-month mortality risk in patients with acute-on-chronic liver failure in hepatitis B: a retrospective cohort study

    The present study was done to establish an objective, sensitive prognostic scoring system and to determine the applicability of this model in predicting the 3-month mortality of patients with acute-on-chronic ...

    Yu-Bao Zheng, Shi-Bin **e, Dong-Ying **e, Liang Peng in Hepatology International (2012)